Global HERG Screening Market By Product Type: (Gene KCNH2, Mutant KCNH2) By Ion-Channel: (Voltage-Gated, Ligand Gated) By Drug Type: (Antiarrhythmic, Antipsychotic, Antibiotic) by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast to 2032.

Published date: Feb 2022
Report ID: 83472
Number of Pages: 320
Format:

- 1. Executive Summary
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
  - 1.4. Key Analysis
  - 1.5. Key Findings by Major Segments
  - 1.6. Top strategies by Major Players
- 2. Global HERG Screening Overview
  - 2.1. HERG Screening Dynamics
    2.1.1. Drivers
    2.1.2. Opportunities
    2.1.2. Restraints
    2.1.4. Challenges
  - 2.2. Macro-economic Factors
  - 2.3. Regulatory Framework
  - 2.4. Market Investment Feasibility Index
  - 2.5. PEST Analysis
  - 2.6. PORTER’S Five Force Analysis
  - 2.7. Drivers & Restraints Impact Analysis
  - 2.8. Industry Chain Analysis
  - 2.9. Cost Structure Analysis
  - 2.10. Marketing Strategy
  - 2.11. Russia-Ukraine War Impact Analysis
  - 2.12. Opportunity Map Analysis
  - 2.13. Market Competition Scenario Analysis
  - 2.14. Product Life Cycle Analysis
  - 2.15. Opportunity Orbits
  - 2.16. Manufacturer Intensity Map
  - 2.17. Major Companies sales by Value & Volume
- 3. Global HERG Screening Analysis, Opportunity and Forecast, 2016-2032
  - 3.1. Global HERG Screening Analysis, 2016-2021
  - 3.2. Global HERG Screening Opportunity and Forecast, 2023-2032
  - 3.3. Global HERG Screening Analysis, Opportunity and Forecast, By Product Type, 2016-2032
    3.3.1. Global HERG Screening Analysis by Product Type: Introduction
    3.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
    3.3.3. Gene KCNH2
    3.3.4. Mutant KCNH2
  - 3.4. Global HERG Screening Analysis, Opportunity and Forecast, By Ion-Channel, 2016-2032
    3.4.1. Global HERG Screening Analysis by Ion-Channel: Introduction
    3.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Ion-Channel, 2016-2032
    3.4.3. Voltage-Gated
    3.4.4. Ligand Gated
  - 3.5. Global HERG Screening Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    3.5.1. Global HERG Screening Analysis by Drug Type: Introduction
    3.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    3.5.3. Antiarrhythmic
    3.5.4. Antipsychotic
    3.5.5. Antibiotic
- 4. North America HERG Screening Analysis, Opportunity and Forecast, 2016-2032
  - 4.1. North America HERG Screening Analysis, 2016-2021
  - 4.2. North America HERG Screening Opportunity and Forecast, 2023-2032
  - 4.3. North America HERG Screening Analysis, Opportunity and Forecast, By Product Type, 2016-2032
    4.3.1. North America HERG Screening Analysis by Product Type: Introduction
    4.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
    4.3.3. Gene KCNH2
    4.3.4. Mutant KCNH2
  - 4.4. North America HERG Screening Analysis, Opportunity and Forecast, By Ion-Channel, 2016-2032
    4.4.1. North America HERG Screening Analysis by Ion-Channel: Introduction
    4.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Ion-Channel, 2016-2032
    4.4.3. Voltage-Gated
    4.4.4. Ligand Gated
  - 4.5. North America HERG Screening Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    4.5.1. North America HERG Screening Analysis by Drug Type: Introduction
    4.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    4.5.3. Antiarrhythmic
    4.5.4. Antipsychotic
    4.5.5. Antibiotic
  - 4.6. North America HERG Screening Analysis, Opportunity and Forecast, By Country , 2016-2032
    4.6.1. North America HERG Screening Analysis by Country : Introduction
    4.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    4.6.2.1. U.S.
    4.6.2.2. Canada
    4.6.2.3. Mexico
- 5. Europe HERG Screening Analysis, Opportunity and Forecast, 2016-2032
  - 5.1. Europe HERG Screening Analysis, 2016-2021
  - 5.2. Europe HERG Screening Opportunity and Forecast, 2023-2032
  - 5.3. Europe HERG Screening Analysis, Opportunity and Forecast, By Product Type, 2016-2032
    5.3.1. Europe HERG Screening Analysis by Product Type: Introduction
    5.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
    5.3.3. Gene KCNH2
    5.3.4. Mutant KCNH2
  - 5.4. Europe HERG Screening Analysis, Opportunity and Forecast, By Ion-Channel, 2016-2032
    5.4.1. Europe HERG Screening Analysis by Ion-Channel: Introduction
    5.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Ion-Channel, 2016-2032
    5.4.3. Voltage-Gated
    5.4.4. Ligand Gated
  - 5.5. Europe HERG Screening Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    5.5.1. Europe HERG Screening Analysis by Drug Type: Introduction
    5.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    5.5.3. Antiarrhythmic
    5.5.4. Antipsychotic
    5.5.5. Antibiotic
  - 5.6. Europe HERG Screening Analysis, Opportunity and Forecast, By Country , 2016-2032
    5.6.1. Europe HERG Screening Analysis by Country : Introduction
    5.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    5.6.2.1. U.K.
    5.6.2.2. Germany
    5.6.2.3. France
    5.6.2.4. Spain
    5.6.2.5. Italy
    5.6.2.6. Russia
    5.6.2.7. Rest of Europe
- 6. Asia-Pacific HERG Screening Analysis, Opportunity and Forecast, 2016-2032
  - 6.1. Asia-Pacific HERG Screening Analysis, 2016-2021
  - 6.2. Asia-Pacific HERG Screening Opportunity and Forecast, 2023-2032
  - 6.3. Asia-Pacific HERG Screening Analysis, Opportunity and Forecast, By Product Type, 2016-2032
    6.3.1. Asia-Pacific HERG Screening Analysis by Product Type: Introduction
    6.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
    6.3.3. Gene KCNH2
    6.3.4. Mutant KCNH2
  - 6.4. Asia-Pacific HERG Screening Analysis, Opportunity and Forecast, By Ion-Channel, 2016-2032
    6.4.1. Asia-Pacific HERG Screening Analysis by Ion-Channel: Introduction
    6.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Ion-Channel, 2016-2032
    6.4.3. Voltage-Gated
    6.4.4. Ligand Gated
  - 6.5. Asia-Pacific HERG Screening Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    6.5.1. Asia-Pacific HERG Screening Analysis by Drug Type: Introduction
    6.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    6.5.3. Antiarrhythmic
    6.5.4. Antipsychotic
    6.5.5. Antibiotic
  - 6.6. Asia-Pacific HERG Screening Analysis, Opportunity and Forecast, By Country , 2016-2032
    6.6.1. Asia-Pacific HERG Screening Analysis by Country : Introduction
    6.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    6.6.2.1. China
    6.6.2.2. Japan
    6.6.2.3. South Korea
    6.6.2.4. India
    6.6.2.5. Rest of Asia-Pacific
- 7. South America HERG Screening Analysis, Opportunity and Forecast, 2016-2032
  - 7.1. South America HERG Screening Analysis, 2016-2021
  - 7.2. South America HERG Screening Opportunity and Forecast, 2023-2032
  - 7.3. South America HERG Screening Analysis, Opportunity and Forecast, By Product Type, 2016-2032
    7.3.1. South America HERG Screening Analysis by Product Type: Introduction
    7.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
    7.3.3. Gene KCNH2
    7.3.4. Mutant KCNH2
  - 7.4. South America HERG Screening Analysis, Opportunity and Forecast, By Ion-Channel, 2016-2032
    7.4.1. South America HERG Screening Analysis by Ion-Channel: Introduction
    7.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Ion-Channel, 2016-2032
    7.4.3. Voltage-Gated
    7.4.4. Ligand Gated
  - 7.5. South America HERG Screening Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    7.5.1. South America HERG Screening Analysis by Drug Type: Introduction
    7.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    7.5.3. Antiarrhythmic
    7.5.4. Antipsychotic
    7.5.5. Antibiotic
  - 7.6. South America HERG Screening Analysis, Opportunity and Forecast, By Country , 2016-2032
    7.6.1. South America HERG Screening Analysis by Country : Introduction
    7.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    7.6.2.1. Brazil
    7.6.2.2. Argentina
    7.6.2.3. Rest of South America
- 8. Middle East and Africa HERG Screening Analysis, Opportunity and Forecast, 2016-2032
  - 8.1. Middle East and Africa HERG Screening Analysis, 2016-2021
  - 8.2. Middle East and Africa HERG Screening Opportunity and Forecast, 2023-2032
  - 8.3. Middle East and Africa HERG Screening Analysis, Opportunity and Forecast, By Product Type, 2016-2032
    8.3.1. Middle East and Africa HERG Screening Analysis by Product Type: Introduction
    8.3.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Product Type, 2016-2032
    8.3.3. Gene KCNH2
    8.3.4. Mutant KCNH2
  - 8.4. Middle East and Africa HERG Screening Analysis, Opportunity and Forecast, By Ion-Channel, 2016-2032
    8.4.1. Middle East and Africa HERG Screening Analysis by Ion-Channel: Introduction
    8.4.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Ion-Channel, 2016-2032
    8.4.3. Voltage-Gated
    8.4.4. Ligand Gated
  - 8.5. Middle East and Africa HERG Screening Analysis, Opportunity and Forecast, By Drug Type, 2016-2032
    8.5.1. Middle East and Africa HERG Screening Analysis by Drug Type: Introduction
    8.5.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Drug Type, 2016-2032
    8.5.3. Antiarrhythmic
    8.5.4. Antipsychotic
    8.5.5. Antibiotic
  - 8.6. Middle East and Africa HERG Screening Analysis, Opportunity and Forecast, By Country , 2016-2032
    8.6.1. Middle East and Africa HERG Screening Analysis by Country : Introduction
    8.6.2. Market Size Absolute $ Opportunity Analysis and Forecast, Country , 2016-2032
    8.6.2.1. GCC
    8.6.2.2. Israel
    8.6.2.3. South Africa
    8.6.2.4. Rest of MEA
- 9. Global HERG Screening Analysis, Opportunity and Forecast, By Region , 2016-2032
  - 9.1. Global HERG Screening Analysis by Region : Introduction
  - 9.2. Market Size Absolute $ Opportunity Analysis and Forecast, By Region , 2016-2032
    9.2.1. North America
    9.2.2. Europe
    9.2.3. Asia-Pacific
    9.2.4. South America
    9.2.5. Middle East and Africa
- 10. Global HERG Screening Competitive Landscape, Market Share Analysis, and Company Profiles
  - 10.1. Market Share Analysis
  - 10.2. Company Profiles
  - 10.3. Abcam PLC
    10.3.1. Company Overview
    10.3.2. Financial Highlights
    10.3.3. Product Portfolio
    10.3.4. SWOT Analysis
    10.3.5. Key Strategies and Developments
  - 10.4. ABR-Affinity BioReagents Inc.
    10.4.1. Company Overview
    10.4.2. Financial Highlights
    10.4.3. Product Portfolio
    10.4.4. SWOT Analysis
    10.4.5. Key Strategies and Developments
  - 10.5. AstraZeneca Plc
    10.5.1. Company Overview
    10.5.2. Financial Highlights
    10.5.3. Product Portfolio
    10.5.4. SWOT Analysis
    10.5.5. Key Strategies and Developments
  - 10.6. Aureus Sciences
    10.6.1. Company Overview
    10.6.2. Financial Highlights
    10.6.3. Product Portfolio
    10.6.4. SWOT Analysis
    10.6.5. Key Strategies and Developments
  - 10.7. Aurora Biomed Inc.
    10.7.1. Company Overview
    10.7.2. Financial Highlights
    10.7.3. Product Portfolio
    10.7.4. SWOT Analysis
    10.7.5. Key Strategies and Developments
  - 10.8. AVIVA Biosciences
    10.8.1. Company Overview
    10.8.2. Financial Highlights
    10.8.3. Product Portfolio
    10.8.4. SWOT Analysis
    10.8.5. Key Strategies and Developments
  - 10.9. B’SYS GmbH
    10.9.1. Company Overview
    10.9.2. Financial Highlights
    10.9.3. Product Portfolio
    10.9.4. SWOT Analysis
    10.9.5. Key Strategies and Developments
  - 10.10. A PerkinElmer Company
    10.10.1. Company Overview
    10.10.2. Financial Highlights
    10.10.3. Product Portfolio
    10.10.4. SWOT Analysis
    10.10.5. Key Strategies and Developments
  - 10.11. Cambridge Bioscience Ltd.
    10.11.1. Company Overview
    10.11.2. Financial Highlights
    10.11.3. Product Portfolio
    10.11.4. SWOT Analysis
    10.11.5. Key Strategies and Developments
  - 10.12. Cellular Dynamics International
    10.12.1. Company Overview
    10.12.2. Financial Highlights
    10.12.3. Product Portfolio
    10.12.4. SWOT Analysis
    10.12.5. Key Strategies and Developments
  - 10.13. Eurofins-Cerep SA
    10.13.1. Company Overview
    10.13.2. Financial Highlights
    10.13.3. Product Portfolio
    10.13.4. SWOT Analysis
    10.13.5. Key Strategies and Developments
  - 10.14. ChanTest Corporation
    10.14.1. Company Overview
    10.14.2. Financial Highlights
    10.14.3. Product Portfolio
    10.14.4. SWOT Analysis
    10.14.5. Key Strategies and Developments
  - 10.15. Charles River Laboratories Inc.
    10.15.1. Company Overview
    10.15.2. Financial Highlights
    10.15.3. Product Portfolio
    10.15.4. SWOT Analysis
    10.15.5. Key Strategies and Developments
  - 10.16. ChemAxon, Molecular Devices LLC
    10.16.1. Company Overview
    10.16.2. Financial Highlights
    10.16.3. Product Portfolio
    10.16.4. SWOT Analysis
    10.16.5. Key Strategies and Developments
  - 10.17. Other Key Players
    10.17.1. Company Overview
    10.17.2. Financial Highlights
    10.17.3. Product Portfolio
    10.17.4. SWOT Analysis
    10.17.5. Key Strategies and Developments
- 11. Assumptions and Acronyms
- 12. Research Methodology
- 13. Contact
- List of Figures
  - Figure 1: Global HERG Screening Revenue (US$ Mn) Market Share by Product Type in 2022
  - Figure 2: Global HERG Screening Market Attractiveness Analysis by Product Type, 2016-2032
  - Figure 3: Global HERG Screening Revenue (US$ Mn) Market Share by Ion-Channelin 2022
  - Figure 4: Global HERG Screening Market Attractiveness Analysis by Ion-Channel, 2016-2032
  - Figure 5: Global HERG Screening Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 6: Global HERG Screening Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 7: Global HERG Screening Revenue (US$ Mn) Market Share by Region in 2022
  - Figure 8: Global HERG Screening Market Attractiveness Analysis by Region, 2016-2032
  - Figure 9: Global HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Figure 10: Global HERG Screening Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Figure 11: Global HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Figure 12: Global HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Figure 13: Global HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 14: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Figure 15: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Figure 16: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Figure 17: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 18: Global HERG Screening Market Share Comparison by Region (2016-2032)
  - Figure 19: Global HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Figure 20: Global HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Figure 21: Global HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Figure 22: North America HERG Screening Revenue (US$ Mn) Market Share by Product Typein 2022
  - Figure 23: North America HERG Screening Market Attractiveness Analysis by Product Type, 2016-2032
  - Figure 24: North America HERG Screening Revenue (US$ Mn) Market Share by Ion-Channelin 2022
  - Figure 25: North America HERG Screening Market Attractiveness Analysis by Ion-Channel, 2016-2032
  - Figure 26: North America HERG Screening Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 27: North America HERG Screening Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 28: North America HERG Screening Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 29: North America HERG Screening Market Attractiveness Analysis by Country, 2016-2032
  - Figure 30: North America HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Figure 31: North America HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 32: North America HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Figure 33: North America HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Figure 34: North America HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 35: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 36: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Figure 37: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Figure 38: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 39: North America HERG Screening Market Share Comparison by Country (2016-2032)
  - Figure 40: North America HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Figure 41: North America HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Figure 42: North America HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Figure 43: Europe HERG Screening Revenue (US$ Mn) Market Share by Product Typein 2022
  - Figure 44: Europe HERG Screening Market Attractiveness Analysis by Product Type, 2016-2032
  - Figure 45: Europe HERG Screening Revenue (US$ Mn) Market Share by Ion-Channelin 2022
  - Figure 46: Europe HERG Screening Market Attractiveness Analysis by Ion-Channel, 2016-2032
  - Figure 47: Europe HERG Screening Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 48: Europe HERG Screening Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 49: Europe HERG Screening Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 50: Europe HERG Screening Market Attractiveness Analysis by Country, 2016-2032
  - Figure 51: Europe HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Figure 52: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 53: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Figure 54: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Figure 55: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 56: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 57: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Figure 58: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Figure 59: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 60: Europe HERG Screening Market Share Comparison by Country (2016-2032)
  - Figure 61: Europe HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Figure 62: Europe HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Figure 63: Europe HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Figure 64: Asia-Pacific HERG Screening Revenue (US$ Mn) Market Share by Product Typein 2022
  - Figure 65: Asia-Pacific HERG Screening Market Attractiveness Analysis by Product Type, 2016-2032
  - Figure 66: Asia-Pacific HERG Screening Revenue (US$ Mn) Market Share by Ion-Channelin 2022
  - Figure 67: Asia-Pacific HERG Screening Market Attractiveness Analysis by Ion-Channel, 2016-2032
  - Figure 68: Asia-Pacific HERG Screening Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 69: Asia-Pacific HERG Screening Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 70: Asia-Pacific HERG Screening Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 71: Asia-Pacific HERG Screening Market Attractiveness Analysis by Country, 2016-2032
  - Figure 72: Asia-Pacific HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Figure 73: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 74: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Figure 75: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Figure 76: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 77: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 78: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Figure 79: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Figure 80: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 81: Asia-Pacific HERG Screening Market Share Comparison by Country (2016-2032)
  - Figure 82: Asia-Pacific HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Figure 83: Asia-Pacific HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Figure 84: Asia-Pacific HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Figure 85: South America HERG Screening Revenue (US$ Mn) Market Share by Product Typein 2022
  - Figure 86: South America HERG Screening Market Attractiveness Analysis by Product Type, 2016-2032
  - Figure 87: South America HERG Screening Revenue (US$ Mn) Market Share by Ion-Channelin 2022
  - Figure 88: South America HERG Screening Market Attractiveness Analysis by Ion-Channel, 2016-2032
  - Figure 89: South America HERG Screening Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 90: South America HERG Screening Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 91: South America HERG Screening Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 92: South America HERG Screening Market Attractiveness Analysis by Country, 2016-2032
  - Figure 93: South America HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Figure 94: South America HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 95: South America HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Figure 96: South America HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Figure 97: South America HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 98: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 99: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Figure 100: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Figure 101: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 102: South America HERG Screening Market Share Comparison by Country (2016-2032)
  - Figure 103: South America HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Figure 104: South America HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Figure 105: South America HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Figure 106: Middle East and Africa HERG Screening Revenue (US$ Mn) Market Share by Product Typein 2022
  - Figure 107: Middle East and Africa HERG Screening Market Attractiveness Analysis by Product Type, 2016-2032
  - Figure 108: Middle East and Africa HERG Screening Revenue (US$ Mn) Market Share by Ion-Channelin 2022
  - Figure 109: Middle East and Africa HERG Screening Market Attractiveness Analysis by Ion-Channel, 2016-2032
  - Figure 110: Middle East and Africa HERG Screening Revenue (US$ Mn) Market Share by Drug Typein 2022
  - Figure 111: Middle East and Africa HERG Screening Market Attractiveness Analysis by Drug Type, 2016-2032
  - Figure 112: Middle East and Africa HERG Screening Revenue (US$ Mn) Market Share by Country in 2022
  - Figure 113: Middle East and Africa HERG Screening Market Attractiveness Analysis by Country, 2016-2032
  - Figure 114: Middle East and Africa HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Figure 115: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Figure 116: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Figure 117: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Figure 118: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Figure 119: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Figure 120: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Figure 121: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Figure 122: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Figure 123: Middle East and Africa HERG Screening Market Share Comparison by Country (2016-2032)
  - Figure 124: Middle East and Africa HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Figure 125: Middle East and Africa HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Figure 126: Middle East and Africa HERG Screening Market Share Comparison by Drug Type (2016-2032)
- List of Tables
  - Table 1: Global HERG Screening Market Comparison by Product Type (2016-2032)
  - Table 2: Global HERG Screening Market Comparison by Ion-Channel (2016-2032)
  - Table 3: Global HERG Screening Market Comparison by Drug Type (2016-2032)
  - Table 4: Global HERG Screening Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 5: Global HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Table 6: Global HERG Screening Market Revenue (US$ Mn) Comparison by Region (2016-2032)
  - Table 7: Global HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Table 8: Global HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Table 9: Global HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 10: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Region (2016-2032)
  - Table 11: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Table 12: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Table 13: Global HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 14: Global HERG Screening Market Share Comparison by Region (2016-2032)
  - Table 15: Global HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Table 16: Global HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Table 17: Global HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Table 18: North America HERG Screening Market Comparison by Ion-Channel (2016-2032)
  - Table 19: North America HERG Screening Market Comparison by Drug Type (2016-2032)
  - Table 20: North America HERG Screening Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 21: North America HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Table 22: North America HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 23: North America HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Table 24: North America HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Table 25: North America HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 26: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 27: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Table 28: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Table 29: North America HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 30: North America HERG Screening Market Share Comparison by Country (2016-2032)
  - Table 31: North America HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Table 32: North America HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Table 33: North America HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Table 34: Europe HERG Screening Market Comparison by Product Type (2016-2032)
  - Table 35: Europe HERG Screening Market Comparison by Ion-Channel (2016-2032)
  - Table 36: Europe HERG Screening Market Comparison by Drug Type (2016-2032)
  - Table 37: Europe HERG Screening Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 38: Europe HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Table 39: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 40: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Table 41: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Table 42: Europe HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 43: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 44: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Table 45: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Table 46: Europe HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 47: Europe HERG Screening Market Share Comparison by Country (2016-2032)
  - Table 48: Europe HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Table 49: Europe HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Table 50: Europe HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Table 51: Asia-Pacific HERG Screening Market Comparison by Product Type (2016-2032)
  - Table 52: Asia-Pacific HERG Screening Market Comparison by Ion-Channel (2016-2032)
  - Table 53: Asia-Pacific HERG Screening Market Comparison by Drug Type (2016-2032)
  - Table 54: Asia-Pacific HERG Screening Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 55: Asia-Pacific HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Table 56: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 57: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Table 58: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Table 59: Asia-Pacific HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 60: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 61: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Table 62: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Table 63: Asia-Pacific HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 64: Asia-Pacific HERG Screening Market Share Comparison by Country (2016-2032)
  - Table 65: Asia-Pacific HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Table 66: Asia-Pacific HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Table 67: Asia-Pacific HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Table 68: South America HERG Screening Market Comparison by Product Type (2016-2032)
  - Table 69: South America HERG Screening Market Comparison by Ion-Channel (2016-2032)
  - Table 70: South America HERG Screening Market Comparison by Drug Type (2016-2032)
  - Table 71: South America HERG Screening Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 72: South America HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Table 73: South America HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 74: South America HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Table 75: South America HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Table 76: South America HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 77: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 78: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Table 79: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Table 80: South America HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 81: South America HERG Screening Market Share Comparison by Country (2016-2032)
  - Table 82: South America HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Table 83: South America HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Table 84: South America HERG Screening Market Share Comparison by Drug Type (2016-2032)
  - Table 85: Middle East and Africa HERG Screening Market Comparison by Product Type (2016-2032)
  - Table 86: Middle East and Africa HERG Screening Market Comparison by Ion-Channel (2016-2032)
  - Table 87: Middle East and Africa HERG Screening Market Comparison by Drug Type (2016-2032)
  - Table 88: Middle East and Africa HERG Screening Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 89: Middle East and Africa HERG Screening Market Revenue (US$ Mn) (2016-2032)
  - Table 90: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Country (2016-2032)
  - Table 91: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Product Type (2016-2032)
  - Table 92: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Ion-Channel (2016-2032)
  - Table 93: Middle East and Africa HERG Screening Market Revenue (US$ Mn) Comparison by Drug Type (2016-2032)
  - Table 94: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Country (2016-2032)
  - Table 95: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Product Type (2016-2032)
  - Table 96: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Ion-Channel (2016-2032)
  - Table 97: Middle East and Africa HERG Screening Market Y-o-Y Growth Rate Comparison by Drug Type (2016-2032)
  - Table 98: Middle East and Africa HERG Screening Market Share Comparison by Country (2016-2032)
  - Table 99: Middle East and Africa HERG Screening Market Share Comparison by Product Type (2016-2032)
  - Table 100: Middle East and Africa HERG Screening Market Share Comparison by Ion-Channel (2016-2032)
  - Table 101: Middle East and Africa HERG Screening Market Share Comparison by Drug Type (2016-2032)
- Abcam PLC
- ABR-Affinity BioReagents Inc.
- AstraZeneca Plc Company Profile
- Aureus Sciences
- Aurora Biomed Inc.
- AVIVA Biosciences
- B’SYS GmbH
- A PerkinElmer Company
- Cambridge Bioscience Ltd.
- Cellular Dynamics International
- Eurofins-Cerep SA
- ChanTest Corporation
- Charles River Laboratories Inc.
- ChemAxon, Molecular Devices LLC
- Other Key Players
Settings

Related Reports

Our Clients

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $5,999 $2,999 USD / per unit save 50%	Multi User $7,999 $3,499 USD / per unit save 55%	Corporate User $12,999 $4,499 USD / per unit save 65%
e-Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 2,999)	Buy Now ($ 3,499)	Buy Now ($ 4,499)